In a patient with ischaemic stroke, intravenous recombinant tissue has mainly been found to be useful during the initia
## **Core Concept**
The use of intravenous recombinant tissue plasminogen activator (rt-PA) in ischemic stroke is based on the principle of thrombolysis. rt-PA works by activating plasminogen to plasmin, which then breaks down blood clots. This intervention aims to restore blood flow to the affected area of the brain, potentially reducing the damage caused by the stroke.
## **Why the Correct Answer is Right**
The correct answer, which is not explicitly provided, generally refers to the time window within which intravenous rt-PA has been found to be most beneficial for patients with ischemic stroke. Clinical trials and guidelines have established that intravenous rt-PA is most effective when administered within 4.5 hours of the onset of stroke symptoms. This time frame is critical because it is during this period that the intervention can significantly improve outcomes by reducing the size of the infarct and improving neurological function.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of the options, we can infer that any option suggesting a time frame significantly longer than 4.5 hours (e.g., 6 hours, 12 hours) would be incorrect. This is because the efficacy of rt-PA significantly diminishes beyond 4.5 hours, and the risk of complications, such as hemorrhage, increases.
- **Option B:** Similarly, if an option suggests a much shorter time frame (e.g., 1 hour, 2 hours), while it might not be incorrect in stating a beneficial window, it could be too restrictive or not the best answer if another option more accurately reflects the currently recommended window.
- **Option D:** Any option suggesting a time frame that does not align with established guidelines (e.g., more than 4.5 hours) would be incorrect.
## **Clinical Pearl / High-Yield Fact**
A critical point to remember is the time-sensitive nature of rt-PA administration in ischemic stroke. The American Heart Association and American Stroke Association guidelines emphasize that intravenous rt-PA should be administered within 4.5 hours of symptom onset. A helpful mnemonic is "FAST": Face, Arm, Speech, Time, emphasizing the urgency of acting quickly.
## **Correct Answer: B. 4.5 hours.**